Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Annie Yoshiyama

Svp, Finance at Allogene Therapeutics, Inc. (ALLO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $29K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 23SEC ALLOAllogene Therapeutics, Inc. Sell 9,586124,517 held (−7%) $2.31 $22K -43.3%
Feb 4SEC ALLOAllogene Therapeutics, Inc. Sell 4,167130,322 held (−3%) $1.72 $7K -23.8%